• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急诊医学中各类血管性水肿病因的发病率及发生频率

The Incidence and Frequency of Various Causes of Angioedema in Emergency Medicine.

作者信息

Karadža-Lapić Ljerka, Pikivaca Tamara, Pervan Petra, Jović Zlatović Josipa, Delin Sanja, Prkačin Ingrid

机构信息

Department of Otorhinolaryngology, General Hospital Šibenik, Šibenik, Croatia.

University of Zagreb, School of Medicine Zagreb, Zagreb, Croatia; Public Health Centre Zagreb, Zagreb, Croatia.

出版信息

Acta Med Acad. 2018 May;47(1):11-17. doi: 10.5644/ama2006-124.210.

DOI:10.5644/ama2006-124.210
PMID:29957967
Abstract

OBJECTIVE

Angioedema (AE) is a potentially life-threatening event. We investigated the etiology of AE, with the emphasis on bradykinininduced angioedema treatment in emergency medicine.

METHODS

The retrospective study included 237 patients with AE, who were examined and treated in two hospitals (group A and B) in Croatia from 2009 to 2016. The location and duration of AE, data about chronic diseases and treatment, potential causative agents (food, drugs, insect bites and chemicals), physical examination data and the subsequent treatment were analyzed.

RESULTS

There was no statistical difference regarding age or comorbidities but there was a statistically significant difference in etiology between the groups (Chi-square, P=0.03). Renin-angiotensin-aldosterone system (RAAS) blocker induced AE was the main cause of emergency attendance in group A (37.5%) and among the leading causes in group B (18.8%). Bradykinin-induced AE (hereditary angioedema (HAE) and RAAS-AE) were the leading causes in a total of 75 (31.5%) patients. RAAS-AE was treated with glucocorticoids and antihistamines. HAE attacks in both groups (2/7 patients, 1.5/6%) were treated with specific therapy. Other causes of AE in groups A/B were insect bites (15/23 patients, 13.5/20%), use of antibiotics/analgetics (11/17 patients, 9/15%), gastroesophageal reflux disease (10/11 patients, 8/9%), neoplasms (5/6 patients, 4/5%) and idiopatic (32/31 patients, 26.5/26%). 21% of patients were hospitalized.

CONCLUSION

Bradykinin-mediated AE was the main cause of emergency attendance associated with AE. Advances in the treatment of HAE, with case reports of patients with RAAS-AE treated with C1 esterase inhibitor concentrate or bradykinin receptor antagonist, may prove to be a new, reliable and efficacious therapy option.

摘要

目的

血管性水肿(AE)是一种可能危及生命的事件。我们对AE的病因进行了调查,重点是急诊医学中缓激肽诱导的血管性水肿的治疗。

方法

这项回顾性研究纳入了237例AE患者,他们于2009年至2016年在克罗地亚的两家医院(A组和B组)接受检查和治疗。分析了AE的部位和持续时间、慢性病及治疗数据、潜在病因(食物、药物、昆虫叮咬和化学物质)、体格检查数据及后续治疗情况。

结果

两组患者在年龄或合并症方面无统计学差异,但病因存在统计学显著差异(卡方检验,P = 0.03)。肾素 - 血管紧张素 - 醛固酮系统(RAAS)阻滞剂诱导的AE是A组急诊就诊的主要原因(37.5%),也是B组的主要病因之一(18.8%)。缓激肽诱导的AE(遗传性血管性水肿(HAE)和RAAS - AE)是总共75例(31.5%)患者的主要病因。RAAS - AE采用糖皮质激素和抗组胺药治疗。两组中的HAE发作(2/7例患者,1.5/6%)均采用特异性疗法治疗。A/B组中AE的其他病因包括昆虫叮咬(15/23例患者,13.5/20%)、使用抗生素/镇痛药(11/17例患者,9/15%)、胃食管反流病(10/11例患者,8/9%)、肿瘤(5/6例患者,4/5%)和特发性(32/31例患者,26.5/26%)。21%的患者住院治疗。

结论

缓激肽介导的AE是与AE相关的急诊就诊的主要原因。HAE治疗方面的进展,以及使用C1酯酶抑制剂浓缩物或缓激肽受体拮抗剂治疗RAAS - AE患者的病例报告,可能证明是一种新的、可靠且有效的治疗选择。

相似文献

1
The Incidence and Frequency of Various Causes of Angioedema in Emergency Medicine.急诊医学中各类血管性水肿病因的发病率及发生频率
Acta Med Acad. 2018 May;47(1):11-17. doi: 10.5644/ama2006-124.210.
2
Nonallergic angioedema: role of bradykinin.非过敏性血管性水肿:缓激肽的作用
Allergy. 2007 Aug;62(8):842-56. doi: 10.1111/j.1398-9995.2007.01427.x.
3
ACE inhibitor-mediated angioedema.血管紧张素转换酶抑制剂相关性血管水肿。
Int Immunopharmacol. 2020 Jan;78:106081. doi: 10.1016/j.intimp.2019.106081. Epub 2019 Dec 10.
4
Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies.缓激肽介导的血管性水肿的流行病学:对流行病学研究的系统调查。
Orphanet J Rare Dis. 2018 May 4;13(1):73. doi: 10.1186/s13023-018-0815-5.
5
Angioedema: etiology, pathophysiology, current and emerging therapies.血管性水肿:病因、病理生理学、现有及新出现的治疗方法。
J Emerg Med. 2013 Nov;45(5):789-96. doi: 10.1016/j.jemermed.2013.03.045. Epub 2013 Aug 29.
6
[Treatment of drugs-associated non-hereditary angioedema mediated by bradykinin].[由缓激肽介导的药物相关性非遗传性血管性水肿的治疗]
Rev Med Suisse. 2016 Jan 13;12(500):11-2.
7
Nanofiltrated C1-esterase-inhibitor in the prophylactic treatment of bradykinin-mediated angioedema.纳米过滤的C1酯酶抑制剂在缓激肽介导的血管性水肿预防性治疗中的应用
Transfusion. 2016 May;56(5):1022-9. doi: 10.1111/trf.13462. Epub 2016 Jan 12.
8
Bradykinin-mediated diseases.缓激肽介导的疾病
Chem Immunol Allergy. 2014;100:140-7. doi: 10.1159/000358619. Epub 2014 May 22.
9
An ABC of the Warning Signs of Hereditary Angioedema.遗传性血管性水肿警示信号ABC
Int Arch Allergy Immunol. 2017;174(1):1-6. doi: 10.1159/000479839. Epub 2017 Sep 27.
10
Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.获得性血管性水肿与遗传性血管性水肿(I/II型)的比较:依卡替班疗效调查结果
Clin Exp Immunol. 2017 Apr;188(1):148-153. doi: 10.1111/cei.12910. Epub 2017 Feb 9.

引用本文的文献

1
CAN'T INTUBATE, CAN'T OXYGENATE: 
A RARE CASE OF A DIFFICULT AIRWAY DUE TO NONHEREDITARY ANGIOEDEMA.无法插管,无法给氧:
一例罕见的遗传性血管性水肿所致困难气道。
Acta Clin Croat. 2022 Jun;61(Suppl 1):99-103. doi: 10.20471/acc.2022.61.s1.17.